|
KMID : 0354720060300040292
|
|
Journal of Korean Diabetes Association
2006 Volume.30 No. 4 p.292 ~ p.302
|
|
|
Efficacy Evaluation of Atorvastatin in Korean Hyperlipidemic Patients with Type 2 Diabetes Mellitus
|
|
Choi Dong-Seop
Kim Duk-Kyu
Kim Doo-Man
Kim Seong-Yeon
Nam Moon-Suk
Park Yong-Soo
Son Ho-Sang
Ahn Chul-Woo
Lee Kwan-Woo
Lee Ki-Up
Lee Moon-Kyu
Chung Choon-Hee
Cha Bong-Yun
|
|
|
Abstract
|
|
|
Background: NCEP ATP III Guideline recommends aggressive treatments of diabetic dyslipidemia, recognizing diabetes mellitus as CHD risk equivalents. This study was conducted to evaluate the effectiveness and safety of atorvastatin in hyperlipidemic patients with Type 2 diabetes mellitus through post-marketing drug use investigation of atorvastatin.
Methods: An open, multi-center, non-comparison, titrated dosage study was conducted in hyperlipidemic patients, who were treated with atorvastatin at first visiting hospitals from Mar. 2004 to Sep. 2004. 96 endocrinologists participated from 66 centers in this study. Total 2,182 hyperlipidemic patients were enrolled and 1,514 patients among them were accompanied by diabetes mellitus. Efficacy was evaluated at later than 4-week treatment by % change of total cholesterol, triglycerides, HDL-cholesterol and LDL-cholesterol from baseline. Percent of patients reaching LDL-cholesterol level less than 100 mg/dL was also analyzed. The adverse events incidence and abnormalities of clinical laboratory values were evaluated for safety monitoring.
Results: Total cholesterol, triglycerides, and LDL-cholesterol level were reduced by 26.6%, 12.0%, and 34.8%, respectively, in diabetic hyperlipidemic patients after atorvastatin treatment. The patients with LDL-cholesterol level of less than 100 mg/dL were increased from 2.8% to 52.6%. Atorvastatin was considered to be safe because adverse drug reactions were reported in 32 patients (1.5%) of total 2,182 patients.
Conclusion: Atorvastatin was effective and safe in hyperlipidemic patients with type 2 diabetes mellitus.
|
|
|
KEYWORD
|
|
|
Atorvastation, Hyperilipidemia, LDL-cholesterol, Total cholesterol, Type 2 diabetes mellitus
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|